(Q28609446)

3 February 2017

title

Soluble interferon-alpha receptor molecules are present in body fluids (English)

1 reference

3 February 2017

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1468582

29 September 2022

D. Novick

1 reference

3 February 2017

B. Cohen

series ordinal

1 reference

3 February 2017

M. Rubinstein

series ordinal

1 reference

3 February 2017

language of work or name

English

0 references

publication date

21 December 1992

1 reference

3 February 2017

1 reference

3 February 2017

volume

314

1 reference

3 February 2017

1 reference

3 February 2017

page(s)

445–448

1 reference

Recent progress in interferon research: molecular mechanisms of regulation, action, and virus circumvention

3 February 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2892%2981523-O

Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2892%2981523-O

Natural interferon alfa for treatment of condylomata acuminata

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2892%2981523-O

Genetic transfer of a functional human interferon alpha receptor into mouse cells: cloning and expression of its cDNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2892%2981523-O

Soluble cytokine receptors are present in normal human urine

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2892%2981523-O

Soluble receptors for IL-1 and IL-4: biological activity and therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2892%2981523-O

Identification of an interleukin-1 beta binding protein in human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2892%2981523-O

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2892%2981523-O

Demonstration of two distinct forms of released low-affinity type interleukin 2 receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2892%2981523-O

The murine interleukin-4 receptor: molecular cloning and characterization of secreted and membrane bound forms

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2892%2981523-O

Isolation of an mRNA encoding a soluble form of the human interleukin-6 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2892%2981523-O

Cloning of the human and murine interleukin-7 receptors: demonstration of a soluble form and homology to a new receptor superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2892%2981523-O

A human inhibitor of tumor necrosis factor alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2892%2981523-O

Serum alpha interferon and lymphocyte inclusions in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2892%2981523-O

Purification of soluble cytokine receptors from normal human urine by ligand-affinity and immunoaffinity chromatography

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2892%2981523-O

Monoclonal antibodies to the soluble human IL-6 receptor: affinity purification, ELISA, and inhibition of ligand binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2892%2981523-O

Enhancement of interleukin 6 cytostatic effect on human breast carcinoma cells by soluble IL-6 receptor from urine and reversion by monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2892%2981523-O

Regulation of alloreactivity in vivo by a soluble form of the interleukin-1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2892%2981523-O

10.1016/0014-5793(92)81523-O

21 January 2018

Identifiers

DOI

0 references

1 reference